3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
2
Wilms Tumor
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Pseudomyxoma Peritonei
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Melanoma
1
Lymphoma, B-Cell
1
Lymphoma
1
Kidney Transplantation
1
Digestive System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Adenocarcinoma, Clear Cell
1
Interventions
Dexamethasone
3
Bortezomib
3
Cyclophosphamide
2
Clinical Protocols
2
isatuximab
1
daratumumab
1
Tissue Banks
1
Rifaximin
1
Lenalidomide
1
Clonal Hematopoiesis
1
Chromatin Immunoprecipitation Sequencing
1
CLR1404
1
Blood Cell Count
1
ARQ531
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Paraproteinemias
×
Alemtuzumab
×
1 year
×
Clear all
No trials found.